Losartan, Ezetimibe Recall Initiated Due to Bottles Not Being Child Resistant

Sandoz announced a voluntary recall of certain lots of Losartan Potassium and Ezetimibe prescription bottles due to not meeting federal standards for child-resistant packaging as required by the Poison Prevention Packaging Act. The specified products include:

• Ezetimibe 10mg; NDC: 0781-5690-31 (30 tabs); NDC: 0781-5690-92 (90 tabs)
• Losartan 50mg; NDC: 0781-5701-31 (30 tabs)

Products affected by this recall were distributed between July 2018 and August 2019; additional information, including specific lot numbers, can be found here.

According to Sandoz, there are no quality or safety issues with the medications for their intended use and no reports of adverse events have been received at this time. Consumers are instructed to secure any recalled medications to keep them out of sight and reach of children.

For more information regarding this recall contact Sandoz, by calling 1-800-525-8747 or visit us.sandoz.com.